Body Image clinical trials

Explore recruiting body image clinical trials.

Recruiting body image studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Body Image trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Short-term changes in cardiovascular risk determinants after temporarily stopping gender-affirming hormone therapy in older transgender women - a pilot study

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

TRANSADO - Evaluation of the effectiveness of hormonal treatment in adolescents suffering from gender dysphoria

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

An interventional, multi-center, randomized, double blinded, placebo controlled study to investigate semaglutide add-on treatment for metabolic control in antipsychotic-using patients (STABIL-NOR – study)

Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

Impact of EXercise on quality of life of early breast cancer patients on treatment with adjuvant Aromatase Inhibitors with or without CDK4/6 inhibitors. "The EX-AI study"

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Improving the empowerment in patients with severe breast fibrosis radio-induced treated by Pravastatin : benefit of e-PROs (electronic « Patient Reported Outcome ») on breast-related quality of life

France

Therapeutic exploratory (Phase II) EU CTIS Study details

C1071032 - MAGNETISMM-32 A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE (PVd) OR CARFILZOMIB, DEXAMETHASONE (Kd) IN PARTICIPANTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA WHO RECEIVED PRIOR ANTI-CD38 DIRECTED THERAPY

Norway, Belgium, Spain, Denmark, Czechia, Sweden +10 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Body Image trials by city

Body Image in Toronto Body Image in Vancouver Body Image in Montreal Body Image in Calgary Body Image in Edmonton Body Image in Ottawa Body Image in Winnipeg Body Image in Quebec City Body Image in Hamilton Body Image in Kitchener Body Image in London Body Image in Halifax Body Image in New York Body Image in Los Angeles Body Image in Chicago Body Image in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease